Characterization of a MnII complex of Alizarin suggests attributes explaining a superior anticancer activity: A comparison with anthracycline drugs

MLA

Mouli Saha, et al. “Characterization of a MnII Complex of Alizarin Suggests Attributes Explaining a Superior Anticancer Activity: A Comparison with Anthracycline Drugs.” Polyhedron, vol. 173, Nov. 2019, p. 114104. EBSCOhost, https://doi.org/10.1016/j.poly.2019.08.007.

APA

Mouli Saha, Soumen Singha, Parimal Karmakar, Sanjay Kumar, Swagata Mazumdar, Mousumi Chakraborty, & Saurabh Das. (2019). Characterization of a MnII complex of Alizarin suggests attributes explaining a superior anticancer activity: A comparison with anthracycline drugs. Polyhedron, 173, 114104. https://doi.org/10.1016/j.poly.2019.08.007

Chicago

Mouli Saha, Soumen Singha, Parimal Karmakar, Sanjay Kumar, Swagata Mazumdar, Mousumi Chakraborty, and Saurabh Das. 2019. “Characterization of a MnII Complex of Alizarin Suggests Attributes Explaining a Superior Anticancer Activity: A Comparison with Anthracycline Drugs.” Polyhedron 173 (November): 114104. doi:10.1016/j.poly.2019.08.007.